COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,562,394 | -35.4% | 11,647,699 | -26.2% | 0.00% | -50.0% |
| Q2 2023 | $67,411,078 | -31.5% | 15,787,138 | +9.7% | 0.00% | -33.3% |
| Q1 2023 | $98,479,343 | -11.7% | 14,397,565 | +2.2% | 0.00% | 0.0% |
| Q4 2022 | $111,531,783 | -10.6% | 14,082,296 | +8.5% | 0.00% | -25.0% |
| Q3 2022 | $124,786,000 | +33.8% | 12,984,843 | +0.8% | 0.00% | +33.3% |
| Q2 2022 | $93,277,000 | -40.1% | 12,883,490 | +6.7% | 0.00% | -25.0% |
| Q1 2022 | $155,851,000 | -18.1% | 12,072,187 | +1.3% | 0.00% | -20.0% |
| Q4 2021 | $190,226,000 | +2.1% | 11,918,855 | +2.8% | 0.01% | 0.0% |
| Q3 2021 | $186,249,000 | +12.0% | 11,589,843 | -3.6% | 0.01% | 0.0% |
| Q2 2021 | $166,245,000 | +1.5% | 12,020,457 | +7.2% | 0.01% | 0.0% |
| Q1 2021 | $163,782,000 | -10.5% | 11,210,180 | +6.5% | 0.01% | -16.7% |
| Q4 2020 | $182,984,000 | -2.3% | 10,528,350 | +3.1% | 0.01% | -14.3% |
| Q3 2020 | $187,266,000 | +2.6% | 10,210,732 | -0.1% | 0.01% | 0.0% |
| Q2 2020 | $182,555,000 | +106.4% | 10,221,364 | +87.5% | 0.01% | +75.0% |
| Q1 2020 | $88,442,000 | -13.4% | 5,452,560 | -3.9% | 0.00% | 0.0% |
| Q4 2019 | $102,127,000 | -4.6% | 5,672,219 | +7.3% | 0.00% | 0.0% |
| Q3 2019 | $107,082,000 | -3.8% | 5,285,371 | +4.9% | 0.00% | -20.0% |
| Q2 2019 | $111,327,000 | +79.2% | 5,037,431 | +10.6% | 0.01% | +66.7% |
| Q1 2019 | $62,115,000 | +45.3% | 4,553,890 | -3.6% | 0.00% | +50.0% |
| Q4 2018 | $42,739,000 | -44.0% | 4,722,418 | +2.1% | 0.00% | -33.3% |
| Q3 2018 | $76,354,000 | +31.6% | 4,627,525 | +11.7% | 0.00% | 0.0% |
| Q2 2018 | $58,018,000 | +57.5% | 4,144,082 | +24.3% | 0.00% | +50.0% |
| Q1 2018 | $36,837,000 | +30.9% | 3,333,724 | +4.2% | 0.00% | +100.0% |
| Q4 2017 | $28,149,000 | -35.7% | 3,198,726 | -2.4% | 0.00% | -50.0% |
| Q3 2017 | $43,761,000 | +3.3% | 3,278,049 | +11.1% | 0.00% | 0.0% |
| Q2 2017 | $42,355,000 | -29.6% | 2,951,581 | +3.8% | 0.00% | -33.3% |
| Q1 2017 | $60,168,000 | +93912.5% | 2,844,827 | +124400.1% | 0.00% | – |
| Q4 2016 | $64,000 | -24.7% | 2,285 | -28.6% | 0.00% | – |
| Q3 2016 | $85,000 | -34.1% | 3,202 | -58.2% | 0.00% | – |
| Q2 2016 | $129,000 | +330.0% | 7,659 | +440.1% | 0.00% | – |
| Q1 2016 | $30,000 | +114.3% | 1,418 | +122.3% | 0.00% | – |
| Q4 2015 | $14,000 | +27.3% | 638 | +18.6% | 0.00% | – |
| Q3 2015 | $11,000 | -31.2% | 538 | 0.0% | 0.00% | – |
| Q2 2015 | $16,000 | – | 538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |